These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34762814)

  • 41. Assessment of laryngeal dysfunctions of dysarthric speakers.
    Surabhi V; Vijayalakshmi P; Steffina L; Jayanthan RV
    Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():2608-11. PubMed ID: 19965223
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of speech cues in French-speaking children with dysarthria.
    Levy ES; Moya-Galé G; Chang YM; Campanelli L; MacLeod AAN; Escorial S; Maillart C
    Int J Lang Commun Disord; 2020 May; 55(3):401-416. PubMed ID: 32077196
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Minimally Detectable Change and Minimal Clinically Important Difference of a Decline in Sentence Intelligibility and Speaking Rate for Individuals With Amyotrophic Lateral Sclerosis.
    Stipancic KL; Yunusova Y; Berry JD; Green JR
    J Speech Lang Hear Res; 2018 Nov; 61(11):2757-2771. PubMed ID: 30383220
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Speech technology-based assessment of phoneme intelligibility in dysarthria.
    Van Nuffelen G; Middag C; De Bodt M; Martens JP
    Int J Lang Commun Disord; 2009; 44(5):716-30. PubMed ID: 18821111
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Impact of Clear Speech on the Perceptual and Acoustic Properties of Fricative-Vowel Sequences in Speakers With Dysarthria.
    Martel-Sauvageau V; Breton M; Chabot A; Langlois M
    Am J Speech Lang Pathol; 2021 Jun; 30(3S):1410-1428. PubMed ID: 33784184
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship between acoustic measures and speech naturalness ratings in Parkinson's disease: A within-speaker approach.
    Klopfenstein M
    Clin Linguist Phon; 2015; 29(12):938-54. PubMed ID: 26403503
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acoustic and intelligibility characteristics of sentence production in neurogenic speech disorders.
    Weismer G; Jeng JY; Laures JS; Kent RD; Kent JF
    Folia Phoniatr Logop; 2001; 53(1):1-18. PubMed ID: 11125256
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Comparative Study of Auditory-Perceptual Speech Measures for the Early Detection of Mild Speech Impairments.
    Kuruvilla-Dugdale M; Threlkeld K; Salazar M; Nolan G; Heidrick L
    Semin Speech Lang; 2019 Nov; 40(5):394-406. PubMed ID: 31426103
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Speech intelligibility in people with Amyotrophic Lateral Sclerosis (ALS).
    Leite Neto L; França Júnior MC; Chun RYS
    Codas; 2021; 33(1):e20190214. PubMed ID: 33533830
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysing spectral changes over time to identify articulatory impairments in dysarthria.
    Slis A; Lévêque N; Fougeron C; Pernon M; Assal F; Lancia L
    J Acoust Soc Am; 2021 Feb; 149(2):758. PubMed ID: 33639779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Classifications of vocalic segments from articulatory kinematics: healthy controls and speakers with dysarthria.
    Yunusova Y; Weismer GG; Lindstrom MJ
    J Speech Lang Hear Res; 2011 Oct; 54(5):1302-11. PubMed ID: 21646421
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vowel-Specific Intelligibility and Acoustic Patterns in Individuals With Dysarthria Secondary to Amyotrophic Lateral Sclerosis.
    Lee J; Dickey E; Simmons Z
    J Speech Lang Hear Res; 2019 Jan; 62(1):34-59. PubMed ID: 30950759
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A clinician-judged technique for quantifying dysarthric speech based on single-word intelligibility.
    Yorkston KM; Beukelman DR
    J Commun Disord; 1980 Jan; 13(1):15-31. PubMed ID: 7354139
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acoustic variation during passage reading for speakers with dysarthria and healthy controls.
    Kuo C; Tjaden K
    J Commun Disord; 2016; 62():30-44. PubMed ID: 27219893
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dysarthria following acute ischemic stroke: Prospective evaluation of characteristics, type and severity.
    De Cock E; Oostra K; Bliki L; Volkaerts AS; Hemelsoet D; De Herdt V; Batens K
    Int J Lang Commun Disord; 2021 May; 56(3):549-557. PubMed ID: 33580596
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Construct-related validity of the TOCS measures: comparison of intelligibility and speaking rate scores in children with and without speech disorders.
    Hodge MM; Gotzke CL
    J Commun Disord; 2014; 51():51-63. PubMed ID: 25069811
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predicting Intelligibility Gains in Dysarthria Through Automated Speech Feature Analysis.
    Fletcher AR; Wisler AA; McAuliffe MJ; Lansford KL; Liss JM
    J Speech Lang Hear Res; 2017 Nov; 60(11):3058-3068. PubMed ID: 29075755
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characteristics of speaking rate in the dysarthria associated with amyotrophic lateral sclerosis.
    Turner GS; Weismer G
    J Speech Hear Res; 1993 Dec; 36(6):1134-44. PubMed ID: 8114480
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intonation and speech rate in dysarthric speech.
    Le Dorze G; Ouellet L; Ryalls J
    J Commun Disord; 1994 Mar; 27(1):1-18. PubMed ID: 8006203
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of Cognitive Impairment and Dysarthria on Spoken Language in Multiple Sclerosis.
    Feenaughty L; Guo LY; Weinstock-Guttman B; Ray M; Benedict RHB; Tjaden K
    J Int Neuropsychol Soc; 2021 May; 27(5):450-460. PubMed ID: 33190658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.